Bayer Pays $24M To Settle Yaz, Yasmin Gallbladder Cases
A federal judge gave approval to Bayer HealthCare Pharmaceuticals Inc.'s settlement to pay $24 million to patients claiming they developed gallbladder disease or had their gallbladders removed after using Bayer's Yaz...To view the full article, register now.
Already a subscriber? Click here to view full article